Revenue breakdown: Sale Of Goods (96.1%), Service (3.9%).
8-K
Nutriband Inc.'s Board of Directors approved the immediate termination of the agreement to sell its subsidiary Pocono Pharmaceuticals, Inc. to Earth Vision Bio Inc. due to the purchaser's failure to pay late fees after missing the December 31, 2025 closing date. The company had received $30,000 in late fees but no further payments since January 21, 2026.